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ABSTRACT
Background Testicular dysgenesis syndrome (TDS) is
a common disease that links testicular germ cell cancer,
cryptorchidism and some cases of hypospadias and male
infertility with impaired development of the testis. The
incidence of these disorders has increased over the last
few decades, and testicular cancer now affects 1% of
the Danish and Norwegian male population.
Methods To identify genetic variants that span the four
TDS phenotypes, the authors performed a genome-wide
association study (GWAS) using Affymetrix Human SNP
Array 6.0 to screen 488 patients with symptoms of TDS
and 439 selected controls with excellent reproductive
health. Furthermore, they developed a novel integrative
method that combines GWAS data with other TDS-
relevant data types and identiﬁed additional TDS
markers. The most signiﬁcant ﬁndings were replicated in
an independent cohort of 671 Nordic men.
Results Markers located in the region of TGFBR3 and
BMP7 showed association with all TDS phenotypes in
both the discovery and replication cohorts. An
immunohistochemistry investigation conﬁrmed the
presence of transforming growth factor b receptor type
III (TGFBR3) in peritubular and Leydig cells, in both fetal
and adult testis. Single-nucleotide polymorphisms in the
KITLG gene showed signiﬁcant associations, but only
with testicular cancer.
Conclusions The association of single-nucleotide
polymorphisms in the TGFBR3 and BMP7 genes, which
belong to the transforming growth factor b signalling
pathway, suggests a role for this pathway in the
pathogenesis of TDS. Integrating data from multiple
layers can highlight ﬁndings in GWAS that are biologically
relevant despite having border signiﬁcance at currently
accepted statistical levels.
INTRODUCTION
Infertility, cryptorchidism, small testis size with
poor semen quality, and hypospadias are relatively
common among men in Western countries and are
all risk factors for testicular germ cell cancer
(TGCC),
1 2 which has been increasing in incidence
and is the most common malignancy of young
men in many countries.
3 Caucasian men are at
particularly high risk of testicular cancer, which
currently affects w1% of the Danish and Norwe-
gian male populations.
4 It has been proposed that
most cases of TGCC, and some cases of hypospa-
dias, cryptorchidism and decreased spermatogenesis
(excluding those unrelated to development of the
fetal testis) may be symptoms of a testicular
dysgenesis syndrome (TDS) that originates from
perturbations during fetal development.
25
Recent progress in basic and epidemiological
research on testis cancer has provided evidence that
TGCC, in spite of its occurrence in young adult
men, has its origin in fetal germ cells with stem cell
characteristics,
6 7 the so-called intratubular carci-
noma in situ (CIS) germ cells.
8 According to
a widely tested hypothesis, these cells are derived
from gonocytes that failed to differentiate to sper-
matogonia because of dysfunction of Sertoli, peri-
tubular and Leydig cells, the function of which is
essential for differentiation of fetal germ cells.
69
However, the invasive potential of CIS cells is not
attained until after the pituitaryegonadal axis is
activated during puberty.
Little is known about the causes of TDS,
although environmental and lifestyle factors appear
to play an important role, as suggested by the rapid
increase in incidence of TGCC over a couple of
generations.
3 The prevalence of mild forms of
cryptorchidism and poor semen quality also appear
to be increasing.
10 11 There is evidence of a genetic
contribution, as brothers and fathers of patients
with TGCC have a signiﬁcantly increased risk of
TGCC.
12 Marked ethnic differences in risk of
TGCC among men living in the same areas also
indicate a clear genetic component in the aetiology
of the disease.
3 Three genome-wide association
studies (GWASs)
13e15 and a replication study
16
have recently identiﬁed several genetic loci that
predispose to TGCC (KITLG, SPRY4, TERT-
CLPTM1L, ATF7IP and DMRT1). Altogether, these
loci can potentially explain up to 13% of the heri-
tability. The variants with highest effect size were
found at 12q21, implicating KITLG/KIT signalling
as a pathway involved in TGCC susceptibility.
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Complex traitsOn the basis of our hypothesis that patients with TDS may
be genetically predisposed to as yet unknown environmental
factors affecting inter-related pathways during testis develop-
ment, we conducted a novel GWAS in which we grouped cases
with at least one of four TDS phenotypes: TGCC, cryptorchi-
dism, hypospadias, or infertility with low sperm concentration.
The GWAS was conducted on a discovery cohort of 926 Danish
men, comprising 439 healthy controls and 488 patients affected
by at least one TDS phenotype. The cohort was carefully
selected with the help of detailed patient records, which
provided background information, and additional phenotype
characterisation including semen analysis. Candidate markers
from the discovery stage were subsequently assessed in an
independent replication cohort of 671 Nordic men. The markers
were selected using three approaches: (1) conventional single-
marker association; (2) an integrative systems biology approach
based on augmenting the GWAS data with several comple-
mentary types of data; and (3) protein-complex-based pathway
analysis, which examined whether groups of related genes in the
same functional pathway were jointly associated with the trait
of interest.
Systems biology approaches that exploit the complementar-
ities of heterogeneous types of data have recently been
successfully applied in GWASs to detect associations that may
be missed by single-marker association.
17e19 Here we used two
such approaches. First, we adapted the MetaRanker tool
20 to
integrate geneephenotype associations from several comple-
mentary data sources, including targeted knockout experiments
in mice, transcriptome time-series expression studies of the
developing testis, and proteineprotein interactions. In a second
approach, we tested protein complexes for association with
TDS, in order to jointly examine multiple markers from genes
inter-related by prior biological knowledge.
21e23
With the above approaches we were able to: (1) identify
pleiotropic risk variants for TDSdthat is, variants associated
with all of the phenotypic subtypes; (2) conﬁrm the risk factors
in the KITLG gene found by two recent GWASs on TGCC;
and (3) identify genes and protein complexes through
integrative systems biology approaches that would not be found
by single-marker association.
MATERIALS AND METHODS
Study subjects
The discovery cohort comprised 927 individuals of Danish
descent: 439 healthy young men with semen concentrations
above 60 million sperm/ml (table 1) and 488 cases (212 men with
germ cell tumours, 138 men with cryptorchidism (diagnosed by
lack of testis descent at birth), 31 men with hypospadias, and
107 infertile men identiﬁed using the following criteria: absence
of any known cause of infertility (no Y-chromosome micro-
deletions and no history of radio- or chemo-therapy); absence of
varicocele; sperm count below 15 million sperm/ml; and testis
volume below 15 ml). Cases with several symptoms of TDS
were grouped according to severity (TGCC>hypospadias>
cryptorchidism>infertility) (supplementary ﬁgure 1 online and
supplementary table 1 online).
The replication cohort included 235 controls and 436 TDS
cases from Denmark, Sweden and Finland, three Nordic popu-
lations that are genetically closely related (supplementary ﬁgure
2 online). Cases of cryptorchidism (n¼103) were contributed
from Finland (Turku area) (n¼34) and from Rigshospitalet
Denmark (n¼69); TGCC samples (n¼333) were collected in
Sweden (from the Malmö region (n¼112) and the Stockholm
area (n¼135)) and Denmark (n¼86); controls were obtained
from Rigshospitalet, Denmark (n¼184) and the Turku area in
Finland (n¼51) (table 1).
For investigations of gene expression at the protein level, we
used nine samples of adult orchiectomy specimens (from men
operated on for testicular tumours), as well as three samples of
normal human fetal testis tissue (originating from spontaneous
miscarriages at 14e15 weeks of gestation). All tissue samples
were parafﬁn-embedded and stored in the pathology archives at
Rigshospitalet.
The local ethics committees approved the study, and all subjects
provided informed consent. The tissue samples were investigated
as coded (adult testes) or anonymous (fetal testes) sections.
Genotyping
The discovery cohort was genotyped using the Affymetrix
Genome-Wide Human SNP Array 6.0, following the manufac-
turer-supplied protocol. Genotype calling and subsequent anal-
ysis were performed using the Birdseed algorithm (of Affymetrix
Power Tools), Plink v1.06 and R. Genotyping of 34 associated
markers and their call rates (supplementary tables 2 and 3
online), selected from the discovery stage, was performed
using the KBiosciences Competitive AlleleSpeciﬁc PCR SNP
genotyping system (KASPar) as an in-house service at KBio-
sciences. KASPar assay primers were designed using the Primer
Picker software available at http://www.kbioscience.co.uk
(KBiosciences). p Values were obtained by the MAX test,
24 and
OR with conﬁdence limits were retrieved by logistic regression
in R.
Quality control
From the 926 samples included in the initial discovery cohort,
we removed 55 for which genotyping call rates were below 96%
or their quality control contrasts were below 0.4. Individuals
detected to be of non-Scandinavian ancestry (n¼11) were
excluded (supplementary ﬁgure 3 online). In addition, 21
samples with high potential for confounding the association
analysis due to risk of consanguinity (n¼17) or a large amount
of missing data (n¼4) were excluded.
Single-marker association statistics
We removed markers with low minor allele frequencies (<0.1),
an excess of missing genotypes (>0.01) or strong deviation from
HardyeWeinberg equilibrium (<10ee5). The resulting 600798
markers were tested for association with the disease phenotypes
using MAX statistics.
24 Multiple testing correction was
performed using the maxT permutation method.
Immunohistochemistry
The polyclonal antibody, transforming growth factor b receptor
III (TGFBR3) (Santa Cruz Biotechnology, Santa Cruz, Cali-
fornia, USA; sc-6199), was used according to a standard indirect
peroxidase protocol based on a Zymed Histostain kit (Invi-
trogen, Carlsbad, California, USA), as previously described.
25
Table 1 Constitution of discovery and replication
cohorts
Phenotype Discovery cohort Replication cohort
Controls 439 235
Infertile 107 0
TGCC 212 333
Hypospadias 31 0
Cryptorchidism 138 103
TGCC, testicular germ cell cancer.
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Complex traitsAll tissue samples were formalin-ﬁxed and parafﬁn-embedded.
For negative controls, the primary antibody was replaced with
the dilution buffer. For fetal testis (14e15 weeks of gestation,
three samples), the same procedure as above was used, except
that the tertiary layer was streptavidin-coupled with alkaline
phosphatase and development was performed with BCIP NBTas
previously described.
26
Gene-level meta-rank analysis
A three-layer MetaRanker analysis
20 was applied to integrate
information from external phenotype-speciﬁc datasets. Ranked
lists of all human genes were obtained in each layer, as described
below, and then combined into a meta-score. Low ranked genes
were considered candidate susceptibility genes.
Layer 1: GWAS evidence
For each gene, a p value was obtained as the minimal GWAS
p value of all markers mapping to the gene according to Affy-
metrix Genome-Wide Human SNP Array 6.0 annotations. The
p values were bias-corrected for gene size, linkage disequilibrium
and marker density, on the basis of the (latent) number of
independent markers.
20 27 All genes were ranked according to the
corrected p values.
Layer 2: expression data from fetal testis
To identify differentially expressed genes in the developing fetal
testis, time-series array expression data from two studies on
mouse fetal testis and from one study on human fetal testis
were retrieved from the Gene Expression Omnibus and
normalised by q-spline normalisation.
28 The study on human
fetal testis was the only one found in the Gene Expression
Omnibus; it provided data on 17 testis samples taken between 9
and 20 weeks of gestation.
29 Genes were ranked according to the
coefﬁcient of variation (the SD of expression divided by the
mean). The mouse studies included data from biological dupli-
cates taken at ﬁve time points between the time of the indif-
ferent gonad (11.5 days postcoitus (dpc)) and birth (18.5 dpc),
30
respectively at ﬁve time points between gestational day 11 and
18.
31 For both mouse studies, genes were ranked on the basis of
one-way analysis of variance F-tests for differential expression at
different time points. A single ranked list of genes that describes
the transcriptional regulation in the developing testis was
obtained by summing the gene ranks from the three studies
(after mapping the mouse genes to their human orthologues).
Layer 3: mouse targeted genes with proteineprotein complexes
All targeted alleles with their human orthologues and associated
morphologies were obtained from the Mouse Genome Infor-
matics (MGI) database via the BioMart interface. A set of 34
morphologies from the Mammalian Phenotype ontology were
manually curated on the basis of their developmental defects of
the testis and relation to TDS (supplementary table 4 online). To
avoid a bias towards spermatogenesis-related genes, two
morphologies, ‘male infertility’ and ‘abnormal spermatogenesis’,
Figure 1 Manhattan plots showing
the association between all single-
nucleotide polymorphisms and (A)
testicular dysgenesis syndrome and (B)
the subset of cases of testicular germ
cell cancer.
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Complex traitswere excluded. All descendants to the curated terms were then
retrieved from the Mammalian Phenotype ontology, resulting in
a total of 122 terms. This set of terms was mapped to 315
human orthologous genes that were targeted in MGI. Next, we
ranked all human protein complexes according to their enrich-
ment for these 315 targeted genes. A complex was deﬁned as
a central hub protein and all its ﬁrst-order interaction partners in
a network of proteineprotein interactions.
32 Each complex was
tested for enrichment of targeted genes using a hyper-geometric
test. In this manner, all sets of genes interacting in a biologically
active complex obtained a rank with respect to its enrichment of
TDS targeted mouse genes.
Integration of three evidence layers into a meta-rank
For each gene, let Lj denote the rank from layer j. The meta-score
was obtained as Smeta ¼ L1 þ L2 þ L3:LowSmeta rank indicates
candidate disease genes.
Pathway-based analysis of protein complex association
To complement the single-nucleotide polymorphism (SNP)
GWAS and the gene-centric meta rank analysis, we applied
a proteineprotein interaction-based approach that leverages
GWAS analysis by testing for the aggregate association across
several gene products.
21 Protein complexes were deﬁned and
delineated by use of our previously published proteineprotein
interaction database, InWeb.
32 We ranked 8342 protein
complexes on the basis of their enrichment in genes that harbour
low TDS GWAS association p values. Of particular interest were
complexes with low scores that also contained genes with low
meta-rank from the three-layer MetaRanker analysis.
RESULTS
In this study we genotyped a discovery cohort comprising 439
controls and 488 cases affected by at least one of four TDS sub-
phenotypes: testicular germ cell cancer, cryptorchidism, hypo-
spadias or low semen concentration. Samples were analysed
using the Affymetrix Genome-Wide Human SNP Array 6.0.
After application of stringent quality control criteria, we
compared the genotype frequency distributions between cases
and controls for 600798 markers using the MAX test,
24 which
allows simultaneous investigation of additive, dominant and
recessive inheritance. We observed only marginal confounding
due to population stratiﬁcation or other biases, as indicated
by the genomic inﬂation factor (l) of 1.019 and the quanti-
leequantile plot of observed versus expected c
2 test statistics
(supplementary ﬁgure 4 online).
Table 2 Markers and genes with a possible association with the testicular dysgenesis syndrome (TDS) phenotype
Gene Marker*
Selection
methody Phase
Risk
allele
Control
RAFz
OR (95% CI)
punadj padj
Optimal genetic
modelx Per allele Optimal genetic model
KITLG rs1352947 TGCC Discovery T 0.81 1.56 (1.19 to 2.05) 1.52 (1.18 to 1.97) 3.1310
 3 1 Additive
C/T Replication 0.82 2.11 (1.48 to 3.03) 1.93 (1.39 to 2.69) 8.5310
 5 2.0310
 3
TGFBR3 rs12082710 ISB Discovery T 0.58 1.35 (1.10 to 1.65) 1.77 (1.33 to 2.36) 2.4310
 4 1 Recessive
T/C Replication 0.59 1.27 (0.99 to 1.63) 1.52 (1.08 to 2.15) 1.6310
 2 3.8310
 1
BMP7 rs388286 Pathway Discovery C 0.47 1.34 (1.10 to 1.63) 1.36 (1.11 to 1.67) 2.3310
 3 1 Additive
C/T Replication 0.47 1.29 (1.01 to 1.66) 1.28 (1.01 to 1.62) 4.1310
 2 9.9310
 1
HOXDx rs17198432 TDS Discovery A 0.07 2.31 (1.66 to 3.26) 2.58 (1.82 to 3.70) 4.7310
 8 2.2310
 2 Dominant
C/A Replication 0.11 0.96 (1.43 to 0.64) 0.97 (0.64 to 1.48) 8.7310
 1 1
*The marker with the lowest p value in the discovery cohort, among the markers tagging a gene, is presented.
yFour different approaches were used for the selection of markers: TDS, single-marker genome-wide association study (GWAS) on all TDS sub-phenotypes; TGCC, single-marker GWAS on the
testicular germ cell cancer (TGCC) subset of cases; Pathway, aggregated effect in pathways; ISB, integrative systems biology by combing evidence of association from several data types.
zRisk allele frequency.
xThe genetic model with strongest association among the models tested by the MAX test (selected on discovery cohort).
Figure 2 Integration of genome-wide
association study (GWAS) data with
heterogeneous data types. The
rationale behind the method is to
prioritise genes if several data types
show mildly pronounced associations
with the phenotype, thereby identifying
genes that would not have been found
with GWAS analysis alone. TGFBR3,
which was selected by this method and
whose single-nucleotide polymorphism
markers were further validated, is
shown in red. The position of TGFBR3 is
marked by red circles in the
distributions of p values, and by red
squares in the ranking of each data type
layer. Three data types were used: (1)
single-marker GWAS results of this study (grey); (2) targeted mutations from the Mouse Genome Informatics (MGI) database, ﬁltered for testicular
dysgenesis syndrome phenotypes, and ranked by their enrichment in proteineprotein complexes (pink); (3) differential expression in the fetal testis of
mouse and human (green). (A) A distribution of the p values of all human genes is shown for each of the data types. The p value ranges from 0 to 1,
with 0 at the top. The p value associated with each gene is converted into a rank, such that each human gene is assigned a rank. The vertical line to the
right of each distribution represents the ranking of all genes, where the top corresponds to rank 1. (B) The gene ranks of each individual data type are
combined to a ﬁnal meta-rank of each gene. As an example, TGFBR3 had the ranks 238, 42 and 408 among all human genes in the three data types:
GWAS, targeted mutations with proteineprotein interaction enrichment, and differential expression in the developing testis, respectively. After
combination of these data type-speciﬁc ranks, TGFBR3 was ranked 3rd among all genes. PPI, protein-protein interaction.
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Complex traitsSingle-marker association
We identiﬁed a strong association with all phenotypes of TDS
(p<10
 6) for nine markers, within the same linkage disequilib-
rium block, at 2q31.1, with the strongest association for
rs17198432 (ﬁgure 1). The subset of 212 TGCC cases in our
cohort was investigated in a separate single-marker analysis to
compare the corresponding TGCC-speciﬁc results with those of
two recent GWASs on TGCC.
13e15 The most signiﬁcant marker
at KITLG was ranked 12th among all markers (p¼1.17310
 5).
Furthermore, in the TGCC group, the observed genotype
frequencies of the KITLG markers were comparable to those
previously reported (table 2).
Integration of geneephenotype associations
For each data type, all genes were ranked on the basis of their
strength of association with the TDS phenotype. These data
type-speciﬁc ranked lists of genes were then combined into
a ﬁnal ranked list of genes. In order to avoid high ranking of
genes that were only supported by a single data type, we used
a modiﬁcation of the MetaRanker
20 tool by using the sum rather
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Figure 3 Regional association plots and linkage disequilibrium structure. The  log10 of the p values for the association of discovery markers are
shown, and the markers are coloured in a white to red scale according to the strength of the pairwise linkage disequilibrium (r
2) to the most signiﬁcant
discovery marker at each locus. The blue marker represents the association in the replication stage. Light blue peaks indicate recombination rates from
the CEU HapMap population. r
2-based linkage disequilibrium structures from the genome-wide association study data are displayed at the bottom. (A)
The strongest association in the discovery stage was found at 2q31.1, close to the cluster of HOXD genes. (B) The most signiﬁcant markers in the
replication stage were found at the KITLG region. The genes TGFBR3 (C) and PBM7 (D) had single-nucleotide polymorphisms with mild association in
the discovery stage, but were top-ranked by the integrative data analysis, and were further validated in the replication stage.
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Complex traitsthan the product of the individual gene ranks. Thus all human
genes were ranked on the basis of a combination of microarray
gene expression time-series studies of the developing fetal testis
in mouse and human,
29e31 proteineprotein interaction data,
32
targeted mice knockouts resulting in developmental defects of
the testis (MGI), and gene scores based on the single-marker
analysis of this GWAS (ﬁgure 2; see Materials and methods for
details). From this analysis, we selected markers from 14 top-
ranked genes, many of which are active during early develop-
ment (supplementary tables 5 and 6 online). Genes implicated
by previous GWASs of TGCC had relatively poor ranks
(supplementary tables 7 and 8 online), partly because we used
a TDS cohort rather than solely TGCC cases and partly because
the genes did not exhibit any signiﬁcant variable expression
during testicular development.
Pathway analysis
Joint analysis of sets of markers may identify aggregated effects
that are signiﬁcant at a pathway level. Such analysis is moti-
vated by the hypothesis that a set of genetic variations can
perturb different components of a certain biologically functional
entity, such as a signalling pathway or a protein complex, and
each variation can inﬂuence the functional entity either indi-
vidually or in combination. Thus we derived protein complexes
from proteineprotein interaction data, and tested each complex
for signiﬁcant enrichment of TDS-associated SNPs. A complex
consisting of interacting members of the TGFb superfamily
(BMPER, BMP2, BMP7, BMP6 and BMP4) was found to be
signiﬁcantly associated (supplementary table 9 online).
Validation
On the basis of the ﬁndings from the marker selection
approaches described above (TDS single-marker association,
integration of geneephenotype association and pathway anal-
ysis) and previously reported KITLG markers with association
with TGCC, we selected a total of 39 SNPs (supplementary table
2 online) for subsequent validation in an independent replication
cohort of 671 Nordic men. These included 16 SNPs from four
independent loci based on single-marker association, and 23 SNPs
based on integration of gene association ranks from different
data types and protein complex ranks based on pathway anal-
ysis. Of the 671 samples, 23 did not meet the quality control
standards for the genotyping system used by KBiosciences.
Markers at three genes showed a signiﬁcant association in the
replication cohort: KITLG, TGFBR3 and BMP7 with OR (95%
CI) 1.93 (1.39 to 2.69), 1.52 (1.08 to 2.15), 1.28 (1.01 to 1.62)
(table 2). Surprisingly, the nine SNPs located in the HOXD
region that were identiﬁed by the single-marker association in
the discovery cohort did not ﬁnd support in the validation
cohort (table 2 and ﬁgure 3). Comparison of ORs for the
different phenotypes of TDS showed that KITLG was mainly
associated with TGCC, but not with the other TDS sub-
phenotypes, whereas TGFBR3 and BMP7 showed similar asso-
ciation for all phenotypes (table 3).
For further investigation of TGFBR3 expression at the protein
level, we performed an immunohistochemical analysis in fetal
and adult testis (ﬁgure 4). Leydig cells and peritubular cells were
TGFBR3-positive, predominantly at cell membranes, in both
normal fetal testes and adult testes with dysgenetic features,
such as the presence of CIS cells, hyperplastic Leydig cell
micronodules and thickened peritubular membranes. Fetal
gonocytes, CIS cells and other types of germ cells were negative,
except for a very few scattered CIS cells in adluminal location
and some staining in Golgi apparatus/pre-acrosome in round
spermatids, which may be unspeciﬁc reactions. In contrast with
a previous study,
33 TGFBR3 protein was not detected in Sertoli
cells, probably because of the differences in tissue ﬁxation
methods or speciﬁcity of the antibodies used.
DISCUSSION
This study focused on understanding the genetics behind devel-
opmental TDS, which is typically associated with male infertility
and TGCC, sometimes combined with mild forms of genital
malformations. Some studies suggest that a common genetic
background for TDS is doubtful,
1 and others have even implied
that TDS does not exist.
34 We believe that TDS is a real
syndrome with predominantly environment-dependent patho-
genesis and a relatively weak component of genetic predisposi-
tion. This means that the prevalence of TDS among Caucasian
populations probably depends on the strength of the adverse
environmental or lifestyle factors. However, as this study
suggests, it is likely that a subset of cases of TDS do share
predisposing genetic variants. Here, we identiﬁed, using a combi-
nation of GWAS and systems biology approaches, genomic
variants in TGFBR3 and BMP7 between several TDS phenotypes,
most notably cryptorchidism and testicular cancer. TGFBR3 has
not previously been reported to be directly associated with male
infertility or TDS, but participates in pathways that are highly
relevant in terms of involvement in regulation of embryogenesis
and oncogenesis. In the single-marker approach, we also found
evidence in the discovery cohort for a possible association for
rs17198432 and other markers in the HOXD gene cluster.
It should be mentioned that SNP markers found to be
signiﬁcant in GWASs are more often than not in intergenic
regions and not in coding or known regulatory regions. Picking
the closest gene as the affected one is an assumption; however,
cis-eQTL studies
35 have shown that it is a reasonable
Table 3 Associations with TDS and its sub-phenotypes, TGCC, cryptorchidism, hypospadias and infertility for the top markers in the discovery stage
and for replicated markers
Gene Marker Phase Risk allele
OR (95% CI)
TDS TGCC Cryptorchidism Hypospadias Infertility
KITLG rs1352947 Discovery T 1.56 (1.18 to 1.97) 2.74 (1.82 to 4.26) 1.08 (0.77 to 1.55) 1.00 (0.52 to 2.11) 1.26 (0.86 to 1.90)
Replication 1.93 (1.39 to 2.69) 2.23 (1.55 to 3.28) 1.38 (0.89 to 2.24) na na
TGFBR3 rs12082710 Discovery T 1.77 (1.33 to 2.36) 1.55 (1.07 to 2.23) 1.62 (1.07 to 2.44) 2.04 (0.90 to 4.56) 2.38 (1.54 to 3.70)
Replication 1.52 (1.08 to 2.15) 1.49 (1.04 to 2.14) 1.64 (0.99 to 2.71) na na
BMP7 rs388286 Discovery C 1.36 (1.11 to 1.67) 1.38 (1.06 to 1.79) 1.49 (1.11 to 2.01) 1.24 (0.70 to 2.22) 1.21 (0.89 to 1.66)
Replication 1.28 (1.01 to 1.62) 1.37 (1.06 to 1.78) 1.09 (0.78 to 1.52) na na
HOXDx rs17198432 Discovery A 2.58 (1.82 to 3.70) 2.85 (1.86 to 4.38) 2.9 (1.81 to 4.63) 2.83 (1.11 to 6.64) 1.76 (1.01 to 3.01)
Replication 0.97 (0.64 to 1.48) 0.96 (0.61 to 1.50) 1.00 (0.52 to 1.83) na na
na, these phenotypes were not assessed in the replication stage.
TGCC, testicular germ cell cancer; TDS, testicular dysgenesis syndrome.
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Complex traitsassumption. One of the strengths of our integrative approach is
that it takes a gene focus that increases the probability of the
gene being involved, as it requires the gene to have relevant
expression, as well as proteineprotein interactions of relevance
to the phenotype.
The integrative systems biology analysis, which combined
data from the GWAS with geneephenotype associations found
in complementary data types, including testis developmental
expression data and proteineprotein complexes associated with
testicular developmental defects, identiﬁed several disparate
loci that are functionally linked to the TGFb superfamily
signalling pathway, which were supported by the replication
study. Using GWAS alone, these SNPs would fall into a ‘grey
zone’,
18 and would not have been selected for replication. Many
GWASs suffer from this phenomenon because the number of
samples required to attain genome-wide signiﬁcance can be
unfeasibly high.
Among the loci with the highest signiﬁcance across all four
TDS phenotypes was the TGFBR3 gene, which encodes the
TGFb receptor type III, a co-receptor for inhibins and TGFb1e3,
BMP2, BMP4 and BMP7. TGFBR3 and its co-receptors and
ligands are expressed in most endocrine tissues, including the
testis. TGFBR3 has been identiﬁed in human Sertoli cells and
Leydig cells, both in the normal testis and in tubules with CIS.
36
In this study, we found that TGFBR3 was expressed in both
Leydig and peritubular cells in fetal as well as adult testis, but
was absent from Sertoli cells. This expression pattern supports
the idea that TGFBR3 is essential for embryonic development of
the reproductive system, as silencing of the murine Tgfbr3 gene
resulted in impaired function of fetal Leydig cells and testicular
dysgenesis.
37 In addition, the signalling partners of TGFBR3, the
family of activin receptors, are present in fetal human testis
38
and appear to be dysregulated in testes with TGCC.
33 39 Of
note, among the loci that scored high in both the pathway
analysis and the integration analysis were BMP7 and other bone
morphogenetic proteins, which can bind TGFBR3. The presence
of several components of the same pathway, which have all
previously been implicated in the development of the testis and
early reproductive system, reinforces the validity of the identi-
ﬁed SNPs as possible genetic factors predisposing to TDS.
The analysis of the TGCC subset of cases conﬁrmed the
association of the KITLG locus (12q21) with increased risk of
testicular cancer.
13 14 However, it has been suggested that SNPs
in the KITand KITLG genes may also be involved in infertility,
40
but we did not detect an association for other subtypes of TDS.
Thus, the KITLG region should be further studied to pinpoint
causative variants within KITLG or its regulatory regions. In the
single-marker approach, we also found evidence for a possible
association for rs17198432 and other markers in the HOXD gene
cluster (supplementary table 10 online). HOXD genes encode
a group of transcription factors well known for their importance
in morphogenesis during early embryonic development of limbs
and genitalia,
41 and a direct association with cryptorchidism has
been shown in one study.
42 As HOXD was not supported in the
replication cohort, we have not discussed this in detail, but we
mention it as a variant locus that would be worth screening for
in other cohorts.
Here, we have successfully applied systems biology method-
ologies to prioritise important ﬁndings in a GWAS of a carefully
collected discovery cohort of individuals of Danish ethnic
background with detailed clinical records, and a subsequent
replication cohort with similar phenotypes. The GWAS data
were complemented by integration of multiple data types. This
approach enabled us to identify potentially signiﬁcant variations
that would normally not be prioritised on the basis of genome-
wide multiple testing corrected p values. Two of the three
replicated loci were selected on the basis of systems biology,
indicating that integrative analyses can be useful for candidate
selection of markers that do not reach genome-wide signiﬁcance
in a single-marker association analysis. The candidates identiﬁed
in this study, notably those involved in TGFb superfamily
signalling pathways, provide evidence that at least a subset of
TDS cases may have a common genetic predisposition. The
paucity of informative markers indicates the predominant role of
environmental and lifestyle factors in the pathogenesis of this
syndrome. However, association with the TGFb signalling
pathway has not been shown previously, and this should be
examined further. The ﬁndings should be corroborated in further
independent GWASs, ﬁne-mapping and sequencing studies, or by
mechanistic investigations of the implicated pathways. In any
case, integration of prevailing information via systems biology
approaches holds promise for enhancing future GWASs.
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